To include your compound in the COVID-19 Resource Center, submit it here.

Therapeutics: Pim-1 (PIM1); Pim-2 (PIM2)

Cancer

INDICATION: Multiple myeloma (MM)

In vitro and mouse studies identified a quinazolinone-based inhibitor of PIM1 and PIM2

Read the full 167 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE